Artwork

Contenu fourni par Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

Ep72: Investing in the Future of Digital Therapeutics: Opportunities and Challenges in the Market

37:25
 
Partager
 

Manage episode 373589728 series 2857558
Contenu fourni par Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

In this episode, we hear from David Kim, Managing Director at DigiTx Partners. In their own words DigiTX Partners is a venture firm focused on investing in and supporting early stage startup companies in the digital health space. Launched in 2016 as a joint venture by Astellas Pharma And MPM Capital, DigiTx Partners remains one of a few venture funds exclusively dedicated to the digital health space. In 2018, Astellas continued its endeavor in digital health by forming the Rx Plus Digital Fund with DigiTx Partners as its investment manager.

In this episode, we cover:

  • What are the challenges faced by digital therapeutics in terms of distribution and clinical workflow?
  • What hypothesis does DigiTx on DTx?
  • What are the benefits of standalone vs drug+? Are DigiTx tracking any other modalities?
  • What lessons have DigiTx learned so far?
  • What will be the drivers for new capital injections in DTx especially? What are investors looking for ?
  • What will the drivers of success going forward be for DTx?
  • How will the role of doctors, nurse & pharmacists change in order for the industry overall to scale PDT's?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 episodes

Artwork
iconPartager
 
Manage episode 373589728 series 2857558
Contenu fourni par Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

In this episode, we hear from David Kim, Managing Director at DigiTx Partners. In their own words DigiTX Partners is a venture firm focused on investing in and supporting early stage startup companies in the digital health space. Launched in 2016 as a joint venture by Astellas Pharma And MPM Capital, DigiTx Partners remains one of a few venture funds exclusively dedicated to the digital health space. In 2018, Astellas continued its endeavor in digital health by forming the Rx Plus Digital Fund with DigiTx Partners as its investment manager.

In this episode, we cover:

  • What are the challenges faced by digital therapeutics in terms of distribution and clinical workflow?
  • What hypothesis does DigiTx on DTx?
  • What are the benefits of standalone vs drug+? Are DigiTx tracking any other modalities?
  • What lessons have DigiTx learned so far?
  • What will be the drivers for new capital injections in DTx especially? What are investors looking for ?
  • What will the drivers of success going forward be for DTx?
  • How will the role of doctors, nurse & pharmacists change in order for the industry overall to scale PDT's?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 episodes

Alle episoder

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide